FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Romark Laboratories, L.C. Alinia Recall

Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle

Romark Laboratories, L.C. · Tampa, FL

Risk level
Class II
Reported by FDA
May 13, 2015
Recall ID
D-0983-2015
Check your lot numberHow we source this data

Summary

Romark Laboratories, L.C. recalled Alinia starting Apr 24, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0983-2015 on May 13, 2015. Reason: Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Product description

Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607

Lot numbers, UPCs & expiration codes

Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0983-2015
Classification
Class II
Status
Terminated
Recall initiated
Apr 24, 2015
FDA report date
May 13, 2015
Quantity
32,893 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Romark Laboratories, L.C.

Original FDA data

Every field from FDA enforcement report D-0983-2015, exactly as published.

Show all FDA fields
City
Tampa
State
FL
Status
Terminated
Country
United States
Event ID
70914
Address
3000 Bayport Dr Ste 200
Code information
Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.
Postal code
33607-8416
Report date
May 13, 2015
Product type
Drugs
Recall number
D-0983-2015
Classification
Class II
Recalling firm
Romark Laboratories, L.C.
Product quantity
32,893 bottles
Termination date
Oct 25, 2016
Reason for recall
Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607
Distribution pattern
Nationwide
Recall initiation date
Apr 24, 2015
Initial firm notification
Letter
Center classification date
May 4, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0983-2015, published May 13, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls